Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CABALETTA BIO, INC. (CABA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CABALETTA BIO, INC. (CABA), most recent 12 months reported: net loss $181.32M, free cash flow -$154.21M. Latest balance sheet on file: liquid cash $225.1M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): BioCardia, Inc. · BRAINSTORM CELL THERAPEUTICS INC. · BLACK DIAMOND THERAPEUTICS, INC. · Black Hawk Acquisition Corporation · CANDEL THERAPEUTICS, INC. · CERO THERAPEUTICS HOLDINGS, INC. · CULLINAN THERAPEUTICS, INC. · Cognition Therapeutics, Inc.

Stock screener

Watchlist